Sites: Africa, Marketing, Medical, Retail
Medical community of South Africa
Medical> Cardiology, Chronic diseases, Corporate Social Responsibility, Dental disease, Disease Groups, Ear, nose & throat, Emergency Procedures, Ethical Medicines, Exercise science, Financial services, Food crisis, Generic Medicines, HIV/AIDS, Hospital Groups, Infectious diseases, Malaria, Medical Aid, Medical Research, Medical Technology, Mental health, Neurology, NPO, Nutrition, Obstetrics and Gynaecology, Oncology, Opthalmology, Paediatrics, Pharmaceutical companies, Pharmaceuticals, Public health, Sports science, Surgical Equipment & Products, The Pan African Health Congress 2008, Tuberculosis, Women's health
Africa> Southern Africa, South Africa
Articles
HIV/AIDS Articles


HIV treatment equivalent in Africa and Europe

The one size fits all approach to HIV treatment in Africa gives similar results to a highly individualised approach used in Switzerland.

An article published in the open source journal Plos Medicine, compares two different public health approaches to HIV treatment. The study authors find that the South African approach that used a limited number of drug combinations for all patients was just as effective as the highly individualized approach to drug selection used in Switzerland .

Around 3 million people in sub-Saharan Africa are now receiving antiretroviral treatment using a standardised WHO approach to treatment selection and clinical monitoring. A team of researchers have now investigated whether this approach is as effective as the highly individualised approach to drug selection that occurs in countries such as Switzerland. The difference in treatment regimens for HIV infection between the two countries was quite striking. In South Africa, patients would begin with one of four first-line therapies, and about 25% of them changed to a second-line therapy during the study period. Contrast this with Switzerland, a country that offered 36 first-line regimens and saw about 50% of patients switch to a new regimen during the study. Even with these different approaches to treatment, HIV-1 RNA levels decreased after one year of treatment in patients in both countries. Additionally, both countries saw about 25% of patients develop viral rebound - when viral levels increase after effective initial treatment - within two years.

One notable difference between the two countries, however, was the death rate (especially during the first three months of therapy), which was higher in South Africa than in Switzerland. The researchers suggest that the higher likelihood of South African patients to have advanced AIDS at the beginning of the study could account for this difference. Therefore, there may be gains in initiating therapy as early as possible in South African HIV patients as well as HIV patients in other resource-poor countries.

Read the full article here http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0050148

[10 Jul 2008 12:45]


 SEND TO A FRIEND  |   PRINT


 
Comment on this
 


Share this page (Tell me more)


 
Africa's leading daily advertising, marketing and media news resource for the industry!





Jail4Bail, raising R 1 million for Autism awareness!










Receive free email newsletter
 
Tell a friend about us
 
CONTACT US | ABOUT US | SEND US NEWS | ADVERTISING RATES | sales@bizcommunity.com | +27 (0)21 680 3500
All rights reserved. © 2008. Bizcommunity.com, its sponsors, contributors and advertisers disclaim all liability for any loss, damage, injury or expense that might arise from the use of, or reliance upon, the services contained herein. Privacy policy, Terms of Use.
Connected by: Uninet